Cargando…

The Potential Use of Metabolic Cofactors in Treatment of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is caused by the imbalance between lipid deposition and lipid removal from the liver, and its global prevalence continues to increase dramatically. NAFLD encompasses a spectrum of pathological conditions including simple steatosis and non-alcoholic steatohep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mardinoglu, Adil, Ural, Dilek, Zeybel, Mujdat, Yuksel, Hatice Hilal, Uhlén, Mathias, Borén, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682907/ https://www.ncbi.nlm.nih.gov/pubmed/31336926 http://dx.doi.org/10.3390/nu11071578

Ejemplares similares

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
por: Zeybel, Mujdat, et al.
Publicado: (2022)

Addressing the heterogeneity in liver diseases using biological networks
por: Lam, Simon, et al.
Publicado: (2020)

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
por: Altay, Ozlem, et al.
Publicado: (2019)

The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
por: Zhang, Cheng, et al.
Publicado: (2020)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

New Challenges to Study Heterogeneity in Cancer Redox Metabolism
por: Benfeitas, Rui, et al.
Publicado: (2017)

Personal model‐assisted identification of NAD(+) and glutathione metabolism as intervention target in NAFLD
por: Mardinoglu, Adil, et al.
Publicado: (2017)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Multi-omics approaches for revealing the complexity of cardiovascular disease
por: Doran, Stephen, et al.
Publicado: (2021)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Informing Pharmacokinetic Models With Physiological Data: Oral Population Modeling of L-Serine in Humans
por: Bosley, J. R., et al.
Publicado: (2021)

Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling
por: Agren, Rasmus, et al.
Publicado: (2014)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
por: Rosario, Dorines, et al.
Publicado: (2018)

Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools
por: Björnson, Elias, et al.
Publicado: (2016)

Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet
por: Yang, Hong, et al.
Publicado: (2021)

Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction
por: Arif, Muhammad, et al.
Publicado: (2021)

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans
por: Adiels, Martin, et al.
Publicado: (2015)

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
por: Proffitt, Ceri, et al.
Publicado: (2022)

Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
por: Lam, Simon, et al.
Publicado: (2022)

Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
por: Lovric, Alen, et al.
Publicado: (2018)

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
por: Yang, Hong, et al.
Publicado: (2021)

Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
por: Benfeitas, Rui, et al.
Publicado: (2018)

Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma
por: Bidkhori, Gholamreza, et al.
Publicado: (2018)

Transcriptomics resources of human tissues and organs
por: Uhlén, Mathias, et al.
Publicado: (2016)

Classification of clear cell renal cell carcinoma based on PKM alternative splicing
por: Li, Xiangyu, et al.
Publicado: (2020)

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
por: Li, Xiangyu, et al.
Publicado: (2021)

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
por: Altay, Ozlem, et al.
Publicado: (2021)

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
por: Li, Xiangyu, et al.
Publicado: (2022)

ESS: A Tool for Genome-Scale Quantification of Essentiality Score for Reaction/Genes in Constraint-Based Modeling
por: Zhang, Cheng, et al.
Publicado: (2018)

TCSBN: a database of tissue and cancer specific biological networks
por: Lee, Sunjae, et al.
Publicado: (2018)

Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase
por: Battisti, Umberto Maria, et al.
Publicado: (2023)

An RNA aptamer that shifts the reduction potential of metabolic cofactors
por: Samuelian, John S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tkt136514n03s2klstc6mqs3jm